UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice Journal article
Yin Dou, Jiawei Guo, Yue Chen, Songling Han, Xiaoqiu Xu, Qing Shi, Yi Jia, Ya Liu, Youcai Deng, Ruibing Wang, Xiaohui Li, Jianxiang Zhang. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice[J]. Journal of Controlled Release, 2016, 235, 48-62.
Authors:  Yin Dou;  Jiawei Guo;  Yue Chen;  Songling Han;  Xiaoqiu Xu; et al.
Favorite | TC[WOS]:40 TC[Scopus]:43  IF:10.5/10.6 | Submit date:2018/11/06
Atherosclerosis  Cyclodextrin  Mtor  Nanomedicine  Rapamycin  Sustained Delivery